Literature DB >> 20377183

Elimination of the native structure and solubility of the hVAPB MSP domain by the Pro56Ser mutation that causes amyotrophic lateral sclerosis.

Jiahai Shi1, Shixiong Lua, Justina Shihui Tong, Jianxing Song.   

Abstract

The Pro56Ser mutation in the human VAPB MSP domain causes a familial amyotrophic lateral sclerosis. Here we present the first structural investigation of both wild-type and Pro56Ser mutant MSP domains. The results reveal that the wild-type MSP domain is well-folded at neutral pH but can undergo acid-induced unfolding reversibly. It has a thermodynamic stability energy (DeltaG degrees (N-U)) of 7.40 kcal/mol and is also active in binding to a Nir2 peptide with a K(D) of 0.65 muM. Further determination of its crystal structure reveals that it adopts a seven-strand immunoglobulin-like beta sandwich in which Pro56 adopts the unusual cis-peptide bond conformation that appears to be critical in maintaining the characteristic S-shaped loop. Markedly, the Pro56Ser mutation renders the MSP domain insoluble in buffer. Nevertheless, as facilitated by our recent discovery that "insoluble proteins" can be solubilized in salt-free water, we have successfully characterized the residue-specific conformation of the Pro56Ser mutant by CD and heteronuclear NMR spectroscopy. The Pro56Ser mutant remains lacking of the native tight packing and secondary structures under various conditions and was further characterized as having a non-native helical conformation weakly populated at pH 3.5. Intriguingly, Pro12 located in another S-shaped loop also adopts the cis-peptide bond conformation, and its mutation to Ser is able to make the MSP domain highly insoluble and unfolded like the Pro56Ser mutant. Our study thus implies that the Pro56Ser mutation might lead to ALS by eliminating the native MSP structure, which consequently leads to aggregation and loss of functions under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20377183     DOI: 10.1021/bi902057a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Types and effects of protein variations.

Authors:  Mauno Vihinen
Journal:  Hum Genet       Date:  2015-01-24       Impact factor: 4.132

Review 2.  ChSeq: A database of chameleon sequences.

Authors:  Wenlin Li; Lisa N Kinch; P Andrew Karplus; Nick V Grishin
Journal:  Protein Sci       Date:  2015-06-16       Impact factor: 6.725

Review 3.  Environment-transformable sequence-structure relationship: a general mechanism for proteotoxicity.

Authors:  Jianxing Song
Journal:  Biophys Rev       Date:  2017-12-04

Review 4.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

5.  Loss of VAPB Regulates Autophagy in a Beclin 1-Dependent Manner.

Authors:  Dan Wu; Zongbing Hao; Haigang Ren; Guanghui Wang
Journal:  Neurosci Bull       Date:  2018-08-24       Impact factor: 5.203

6.  Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients.

Authors:  Miguel Mitne-Neto; Marcela Machado-Costa; Maria C N Marchetto; Mario H Bengtson; Claudio A Joazeiro; Hiroshi Tsuda; Hugo J Bellen; Helga C A Silva; Acary S B Oliveira; Monize Lazar; Alysson R Muotri; Mayana Zatz
Journal:  Hum Mol Genet       Date:  2011-06-17       Impact factor: 6.150

7.  Analysis of the key elements of FFAT-like motifs identifies new proteins that potentially bind VAP on the ER, including two AKAPs and FAPP2.

Authors:  Veronika Mikitova; Timothy P Levine
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

8.  Structural, stability, dynamic and binding properties of the ALS-causing T46I mutant of the hVAPB MSP domain as revealed by NMR and MD simulations.

Authors:  Shixiong Lua; Haina Qin; Liangzhong Lim; Jiahai Shi; Garvita Gupta; Jianxing Song
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

9.  VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B.

Authors:  Shaveta Goyal; Garvita Gupta; Haina Qin; Megha Haridas Upadya; Yee Joo Tan; Vincent T K Chow; Jianxing Song
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

10.  Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutations.

Authors:  Garvita Gupta; Haina Qin; Jianxing Song
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.